Orient Pharma Market Cap

Orient Pharma has a market cap or net worth of 8.49 billion as of February 21, 2025. Its market cap has increased by 84.26% in one year.

Market Cap

8.49B

Enterprise Value

8.97B

Revenue

1.07B

Ranking

n/a

PE Ratio

71.26

Stock Price

38.60

Market Cap Chart

Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 8.49B, an increase of 106.18%. That is a compound annual growth rate of 5.86%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	8.49B	5.69%
Dec 31, 2024	8.03B	80.00%
Dec 29, 2023	4.46B	14.13%
Dec 30, 2022	3.91B	11.76%
Dec 30, 2021	3.50B	28.52%
Dec 31, 2020	2.72B	20.11%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	213.05B
Caliway Biopharmaceuticals	142.70B
Bora Pharmaceuticals Co., LTD.	90.22B
Lotus Pharmaceutical	72.97B
Lumosa Therapeutics	39.69B
Oneness Biotech	38.96B
Polaris Group	34.55B
Pegavision	30.65B

Market Cap Rankings